AP
DTIL icon

Arlington Partners’s Precision BioSciences DTIL Stock Holding History

Arlington Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-67
Closed -$3K – 390
2022
Q2 		$3K Hold
67
– – ﹤0.01% 445
2022
Q1 		$6K Hold
67
– – ﹤0.01% 411
2021
Q4 		$15K Buy
+67
New +$18.7K ﹤0.01% 417

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arlington Partners's DTIL Position: Q3 2022 in Review

Arlington Partners sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 67 shares — an estimated $3K sold.

Arlington Partners first reported a position in DTIL in Q4 2021 and held it in 3 quarters. The position peaked at $15K in Q4 2021. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

  • Arlington Partners reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
  • Arlington Partners sold 67 Precision BioSciences shares in Q3 2022, an estimated $3K.
  • Arlington Partners first reported a position in Precision BioSciences in Q4 2021 and held it in 3 quarters.
  • Arlington Partners's Precision BioSciences position peaked at $15K in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on Arlington Partners's 13F filing for Q3 2022, filed 28 Oct 2022.